Impact of Muscle and Tendon Dysfunction in People With Type 2 Diabetes Mellitus (T2D_MTU)
Type 2 Diabetes Mellitus
About this trial
This is an interventional treatment trial for Type 2 Diabetes Mellitus focused on measuring Type 2 Diabetes Mellitus, Muscle and tendon disorders, locomotion capacity, passive stretching
Eligibility Criteria
Inclusion Criteria:
- body mass index between 23 and 30 kg/m2
- moderate level of physical activity in the everyday life (assessed by means of the International Physical Activity Questionnaires, IPAQ)
Exclusion Criteria:
- neuropathy of nondiabetic origin
- severe neuropathy
- foot ulcers
- arterial insufficiency
- arthritis of the ankle/foot
- previous foot/knee surgery
- previous Achille tendon rupture
- previous Charcot foot
- cardiovascular and respiratory deficits that would impede the performance of the locomotion test
- insulin therapy
Sites / Locations
- Sezione di Scienze MotorieRecruiting
Arms of the Study
Arm 1
Arm 2
Experimental
No Intervention
Training group
Control group
T2D patients and controls in the experimental group will undergo 50 telemedicine MOS sessions (15 minutes/day, 5 days/week, 10 weeks). Before the training period all subjects will participate to three different experimental sessions: during the first session a blood sample will be withdrawn and a skin biopsy will be taken; during the second session, muscle-tendon stiffness and muscle function will be evaluated; during the third session, the energy cost of walking will be determined at different speeds. After the training period and 5 weeks after the end of the training period, all subjects will repeat the second and the third sessions.
T2D patients and controls in the control group will not perform any specific training. However, they will participate to the same three sessions as the experimental group.